Cellosaurus LNCaP-PDR1 (CVCL_C0RR)
Cell line name | LNCaP-PDR1 |
---|---|
Synonyms | LNCaP PDR1; LN-PDR1 |
Accession | CVCL_C0RR |
Resource Identification Initiative | To cite this cell line use: LNCaP-PDR1 (RRID:CVCL_C0RR) |
Comments | Population: Caucasian. Selected for resistance to: ChEBI; CHEBI:85993; Palbociclib (Ibrance). Omics: Deep quantitative phosphoproteome analysis. Omics: Transcriptome analysis by RNAseq. Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056. |
Sequence variations |
|
Disease | Prostate carcinoma (NCIt: C4863) |
Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
Hierarchy | Parent: CVCL_0395 (LNCaP) |
Sex of cell | Male |
Age at sampling | 50Y |
Category | Cancer cell line |
Publications | PubMed=29739788; DOI=10.1158/1078-0432.CCR-18-0410; PMCID=PMC6125187 |
Cross-references | |
Cell line databases/resources | cancercelllines; CVCL_C0RR |
Encyclopedic resources | Wikidata; Q112930019 |
Gene expression databases | GEO; GSM2650005
GEO; GSM2650006 GEO; GSM2650007 GEO; GSM2650008 GEO; GSM2650009 GEO; GSM2650010 |
Proteomic databases | PRIDE; PXD006561 |
Entry history | |
Entry creation | 23-Jun-2022 |
Last entry update | 05-Oct-2023 |
Version number | 5 |